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Epithelial progenitor cells of the lung generate all cell types of the mature airway epithelium, among
them the neuroendocrine cells. The balance between formation of pulmonary neuroendocrine and non-
neuroendocrine cells is controlled by Notch signaling. The Notch target gene Hes1 is expressed by non-
neuroendocrine and absent in neuroendocrine cells. The transcription factor Ascl1 is expressed in a
complementary pattern and provides key regulatory information that speciﬁes the neuroendocrine cell
fate. The molecular events that occur after the induction of the neuroendocrine differentiation program
have received little attention. Here we show that Insm1 is expressed in pulmonary neuroendocrine cells,
and that Insm1 expression is not initiated in the lung of Ascl1 mutant mice. We use mouse genetics to
show that pulmonary neuroendocrine cells depend on Insm1 for their differentiation. Mutation of Insm1
blocks terminal differentiation, upregulates Hes1 protein in neuroendocrine cells and interferes with
maintenance of Ascl1 expression. We show that Insm1 binds to the Hes1 promoter and represses Hes1,
and we propose that the Insm1-dependent Hes1 repression is required for neuroendocrine development.
Our work demonstrates that Insm1 is a key factor regulating differentiation of pulmonary neuroendo-
crine cells.
& 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
The terminal buds of the developing lung contain a population
of multipotent epithelial progenitor cells that gives rise to the
diverse cell types found in the mature airway epithelium (Desai
et al., 2014; Hogan et al., 2014; Morrisey and Hogan, 2010; Ten
Have-Opbroek, 1991). Among the cell types generated are neu-
roendocrine cells and the more abundant non-neuroendocrine
cells like Clara and ciliated cells. During development of the lung
epithelium, the ﬁrst cell fate decision made is the one between
neuroendocrine and non-neuroendocrine cells, and neuroendo-
crine cells are the ﬁrst differentiated cell type detected in the
epithelium (Morimoto et al., 2012; Ten Have-Opbroek, 1991).
Neuroendocrine cells were reported to retain developmental
plasticity and generate Clara and ciliated cells upon injury (Song
et al., 2012).
Ascl1 is expressed in precursors and differentiated neu-
roendocrine cells of the lung epithelium. Ascl1 acts as masterInc. This is an open access article u
ier).
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itzerland.regulator in formation of these cells and neuroendocrine cells are
not generated when Ascl1 is mutated (Borges et al., 1997). Notch
activity controls the choice between neuroendocrine and non-
neuroendocrine fates and represses formation of neuroendocrine
cells in the lung epithelium (Morimoto et al., 2012; Ito et al., 2000).
The Notch target gene Hes1 is expressed in non-neuroendocrine
cells and thus in a complementary pattern to Ascl1. In the absence
of Hes1, Ascl1 is upregulated, neuroendocrine cells appear too
early in development and their number is markedly increased (Ito
et al., 2000). It is unclear how the terminal differentiation of lung
neuroendocrine cells is controlled and, in particular, transcription
factors which act downstream of Ascl1 have not been identiﬁed.
Several tumor types arise in lung tissues. The most common
and a highly aggressive form is small-cell lung cancer. Ascl1, CGRP
and Insm1 are among the characteristic markers of small-cell lung
cancer cells (Augustyn et al., 2014; Kelley et al., 1994; Lan et al.,
1993). Pulmonary neuroendocrine cells express many of these
genes under normal physiological conditions, providing evidence
that these tumors originate from neuroendocrine cells. A second
type of tumor, non-small cell lung cancer, expresses markers ty-
pical for the non-neuroendocrine lung epithelium like Hes1 and
CC10 (Yuan et al., 2015; Nasgashio et al., 2011; Sutherland and
Berns, 2010). The availability of lung cancer cell lines can provide a
model for the analyses of transcriptional networks that control
pulmonary neuroendocrine and non-neuroendocrine cell identity.nder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
S. Jia et al. / Developmental Biology 408 (2015) 90–98 91Insm1 encodes a zinc ﬁnger protein that is widely expressed in
developing and adult endocrine cells. Insm1 was ﬁrst detected in
an insulinoma cDNA library, and later observed in many neu-
roendocrine tumor types (Lan and Breslin, 2009; Goto et al., 1992).
Insm1 controls terminal differentiation of many endocrine cell
types, for instance endocrine cells of the pancreas, intestine, pi-
tuitary and adrenal medulla, and Insm1 is essential to maintain
pancreatic β-cells in a mature state (Gierl et al., 2006; Wildner
et al., 2008; Welcker et al., 2013; Osipovich et al., 2014; Jia et al.,
2015). Here we show that Insm1 is expressed in developing pul-
monary neuroendocrine cells and is essential for their differ-
entiation. In Insm1 mutant mice, the neuroendocrine fate is in-
duced as judged by expression of Ascl1, but the terminal differ-
entiation of neuroendocrine cells is blocked. In addition, Hes1 is
expressed ectopically in mutant neuroendocrine cells, and Ascl1
expression is not maintained at late developmental stages. Hes1 is
known to repress Ascl1 in pulmonary cells (Chen et al., 1997; Ito
et al., 2000). We provide evidence that Insm1 directly binds to
regulatory sequences in the Hes1 gene and represses Hes1. Our
data demonstrate that Insm1 is a crucial component of the reg-
ulatory network that controls the differentiation of pulmonary
neuroendocrine cells.2. Materials and methods
2.1. Genotyping, immunohistochemistry, X-gal staining and in situ
hybridization
The primers used for the genotyping of the Insm1lacZ allele have
been described (Gierl et al., 2006). For immunohistochemistry, the
tissue was ﬁxed (4% paraformaldehyde, 0.1 M sodium phosphate,
pH 7.4), cryoprotected in 25% sucrose in PBS, embedded, and
cryosections were cut at 12 μm thickness. The following primary
antibodies were used: guinea pig anti-Insm1 (Jia et al., 2015),
rabbit/chicken anti-β-galactosidase (1:2,500; 55976, MP/1:1000;
ab9361, Abcam), rabbit anti-CGRP (1:4,000; C8198, Sigma), guinea
pig/rabbit anti-Pgp9.5 (1:2,000; Ab5898/1:500; Ab1761, Millipore),
goat anti-Hes1 (1:50; sc-13844, Santa Cruz), goat anti-CC10 (1:50;
sc-9772, Santa Cruz), mouse anti-SSEA1 (1:100; MAB2155, R&D).
Secondary antibodies conjugated to Cy2, Cy3 or Cy5 were used
(1:500; Jackson ImmunoResearch). For quantiﬁcations of the
analyses of E18.5 animals, 4 lungs each were dissected from con-
trol and mutant mice and the entire lung was sectioned. Every
10th section was stained using anti-Pgp9.5 and anti-CGRP anti-
bodies, and proximal and distal airway epithelia were inspected on
20–24 sections/animal (5–6 slides). Neither single nor clustered
Pgp9.5 and CGRP-positive cells were detected. In addition, histo-
logical analyses were performed on lungs from E13.5 and E15.5
mice (4 mice from each genotype). For the analysis of E13.5 lungs,
8 section (2 slides) were analyzed from each animal; for analysis of
E15.5 lungs, 12–16 sections/animal (3–4 slides) were inspected.
Fluorescence was imaged on a Zeiss LSM 700 confocal microscope
and images were processed using Adobe Photoshop software. β-
Galactosidase activity was assessed by X-gal staining as described
(Lobe et al., 1999). For in situ hybridization, tissue was directly
embedded into OCT compound. We used protocols described be-
fore for generation of digoxigenin-labeled riboprobes and hy-
bridization (Wildner et al., 2008).
2.2. ChIP-PCR
Chromatin immunoprecipitation was done essentially as de-
scribed (Jia et al., 2015). For each ChIP-PCR experiment, lungs of
12–15 embryos were used, and each ChIP-PCR experiment was
performed three times using anti-Insm1 and IgG controlantibodies. Brieﬂy, embryonic lungs were cut into 1–3 mm3 pieces,
and the tissue was cross-linked in 1% formaldehyde (15 min, room
temperature). Nuclei were isolated after lysis of cells and chro-
matin was sheared by sonication. Sonication was optimized to
obtain 150–500 bp long DNA fragments. Antibodies against Insm1
were incubated with BSA blocked Protein A Dynabeads (Invitro-
gen), beads were washed and incubated overnight with chromatin
fragments at 4 °C. To remove unspeciﬁcally bound chromatin,
beads were washed seven times in washing buffer (1% NP40, 0.5 M
LiCl, 1 mM EDTA, 0.7% Na-Deoxycholate, 50 mM Hepes-KOH pH
7.5), and chromatin was eluted in elution buffer at 65 °C (50 mM
Tris–HCl pH 8, 10 mM EDTA, 1% SDS). After de-crosslinking, RNase
A and proteinase K digestion, DNA was puriﬁed by phenol–
chloroform extraction and used for PCR analysis. The PCR primers
used for ChIP-PCR are shown in Supplementary material Table 2.
The fragments tested here had previously been identiﬁed to bind
Insm1 in SJ pancreatic β-cells using ChIP-seq (Jia et al., 2015). The
anti-Insm1 antibody used for ChIP-PCR was described (Welcker
et al., 2013) and its speciﬁcity was tested by immunohistology
comparing control and Insm1 mutant tissue, and by western
blotting using control and mutant tissue (Jia et al., 2015).
2.3. Luciferase assay and RT-PCR analyses
DNA fragments (average size 400–800 bp) were cloned up-
stream of a minimal promoter driving the ﬁreﬂy luciferase gene
(pGL4.23[luc2/minP] vector; Promega). HEK293 cells were trans-
fected with the ﬁreﬂy luciferase plasmid containing putative en-
hancer sequences using Lipofectamine 2000 (Life technologies); as
internal control, a Renilla luciferase plasmid (pRL-TK Renilla;
Promega) was co-transfected. Cell lysates were prepared 24 h after
transfection, and luciferase activity was determined using the
Dual-Luciferases Reporter Assay kit (Promega). For each sample,
ﬁreﬂy luciferase values were normalized to Renilla luciferase va-
lues. We display relative luciferase activity as fold change com-
pared to empty pGL4.23 vector. Primers used for ampliﬁcation of
fragments are listed in Supplementary material Table 2.
Cells were transfected with Insm1 expression plasmids as de-
scribed (Welcker et al., 2013). Cells were lysed and total RNA was
isolated using Trizol reagent (Invitrogen). RT-PCR analysis after
ﬁrst-strand cDNA synthesis was performed using a CFX96 RT-PCR
system (Bio-Rad) and ABsolute QPCR SYBR Green Mix (Thermo
Fisher Scientiﬁc). Primers used are listed in Supplementary ma-
terial Table 2.
2.4. Western blot analyses
Proteins were extracted from transfected cells using RIPA buf-
fer. After centrifugation, supernatants were run on 12% PAGE gels
and the separated proteins were transferred to PVDF membranes
(Millipore). The Insm1 antibody was used for western blot analysis
(1:10,000). Secondary antibodies coupled to horseradish perox-
idase (Dianova) were used, and blots were developed on a Chemi-
smart 3000 (Vilber).3. Results
3.1. Insm1 is essential for the differentiation of pulmonary neu-
roendocrine cells
During lung development, Insm1 protein appears around E13.5
in scattered epithelial cells (Fig. 1A). Pgp9.5 and CGRP mark neu-
roendocrine cells and, in normal development, these proteins
begin to be expressed at E14.5 and E16.5, respectively (Fig. 1A).
Cells co-expressing Pgp9.5 and Insm1 appeared at E14.5, and cells
Fig. 1. Insm1 is expressed in pulmonary neuroendocrine cells during development and in the adult. (A) Immunohistological analysis of Insm1 protein (red) in the developing
(E13.5–E16.5) and adult lung epithelium. Insm1 is co-expressed with Pgp9.5 and CGRP (green). (B and C) Immunohistological analysis of β-gal (red) and Pgp9.5 (green) or
CGRP (green) in neuroendocrine cells of the distal (B) and proximal (C) lung epithelium of control (Insm1þ /lacZ) and Insm1 mutant (Insm1lacZ/lacZ) mice at E18.5. (D) X-gal
staining of the lung of heterozygous Insm1þ /lacZ mice (E18.5). Scale bars: 15 μm (A, B, C); 500 μm (D).
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neuroendocrine cells are present as single cells or in clusters called
neuroendocrine bodies, and both expressed Insm1, but expression
of Pgp9.5 and CGRP was lower in single Insm1þ than clustered
Insm1þ cells (Fig. 1B and C). Furthermore, Insm1 continues to be
co-expressed with CGRP in pulmonary neuroendocrine cells of the
adult (Fig. 1A). Insm1þ /lacZ mice are heterozygous and carry one
Insm1 wildtype and one null allele in which Insm1 coding se-
quences are replaced by lacZ cDNA (Gierl et al., 2006). LacZ en-
codes β-galactosidase, and β-galactosidaseþ cells are found in the
proximal and distal lung epithelium, as assessed by X-gal staining
of the lung from Insm1þ /lacZ mice at E18.5 (Fig. 1D). We concludethat Insm1þ or β-galactosidaseþ cells in the lung co-express
Pgp9.5 or CGRP, demonstrating that they correspond to pulmonary
endocrine cells.
To determine the function of Insm1 in the lung, we analyzed
Insm1 mutant (Insm1lacZ/lacZ) mice. Cells that expressed Pgp9.5 or
CGRP in the lung of E18.5 Insm1mutant mice were not observed in
the proximal or distal epithelium (Fig. 1B and C). Nevertheless, β-
galactosidase was present in some of the cells of the lung epi-
thelium of Insm1 mutant animals. Expression of β-galactosidase
provided the ﬁrst evidence that the neuroendocrine cell fate was
correctly initiated in Insm1mutants. However, their differentiation
was impaired, as demonstrated by the absence of Pgp9.5 or CGRP
Fig. 2. Mutation of Insm1 blocks neuroendocrine cell differentiation. (A-C) Immunohistological analysis of lung tissue from control (Insm1þ /lacZ) and Insm1 mutant
(Insm1lacZ/lacZ) mice at the indicated developmental stages using antibodies directed against Pgp9.5 (green) and β-gal (red). Note that Pgp9.5 expression is initiated but not
maintained in the β-gal-positive neuroendocrine cells. Scale bar: 10 μm.
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thelium, and in 115 β-galactosidaseþ clusters in the distal lung
epithelium (n¼4). Thus, the differentiation deﬁcit was fully pe-
netrant (Fig. 1B and C). Despite the fact that clustered β-
galactosidaseþ cells were present, the average number of cells in
the clusters was smaller in mutants than in control mice
(15.171.6 and 9.471.8 β-galactosidaseþ cells per cluster in the
lungs of Insm1lacZ/þ and Insm1lacZ/lacZ animals, respectively;
Po0.01 in 2-tailed unpaired Student's t-test).
We further investigated the speciﬁcation and differentiation of
pulmonary neuroendocrine cells at different developmental
stages. Pgp9.5 protein begins to be expressed at E14.5 in control
mice, and we observed reduced levels of Pgp9.5 at this stage in
Insm1 mutant lung epithelium (Fig. 2A). However, at subsequent
stages (E16.5 and E18.5), Pgp9.5 was no longer detectable (Fig. 2B
and C).
3.2. Hes1 is ectopically expressed in pulmonary neuroendocrine cells
of Insm1 mutant mice
Hes1 regulates the balance between neuroendocrine and non-
neuroendocrine cells in the airway epithelium and is broadly ex-
pressed in non-neuroendocrine cells (Ito et al., 2000; Shan et al.,
2007). In accordance, we detected Hes1 protein in pulmonary
epithelial cells by immunohistology. β-Galactosidaseþ neu-
roendocrine cells were always Hes1 negative in the lung of het-
erozygous Insm1þ /lacZ mice. In contrast, the majority of β-ga-
lactosidase-positive neuroendocrine cells co-expressed Hes1 in
Insm1 mutant mice at E15.5 and E18.5 (Fig. 3A–C).
Hes1 is known to suppress Ascl1, the transcription factor that
functions as a master regulator of neuroendocrine development(Chen et al., 1997). We next analyzed Ascl1 expression and ob-
served that Ascl1 was expressed in a comparable pattern at E13.5
in the lung of control and Insm1 mutant embryos (Fig. 3D). Ascl1
expression levels were reduced at E15.5, and expression was no
longer detectable at E18.5 (Fig. 3E and F). Ascl1 downregulation
and Hes1 upregulation coincide thus in the lung of Insm1 mutant
mice.
Dll1 is a direct target of Ascl1 and expressed in neuroendocrine
cells of pulmonary epithelia (Ito et al., 2000). We also analyzed
Dll1 expression and observed a marked downregulation of Dll1
mRNA in the lung epithelium of Insm1 mutant mice at E18.5
(Fig. 3G). Thus, neuroendocrine cells in the lung are correctly
speciﬁed, as assessed by Ascl1 and β-galactosidase expression in
Insm1lacZ/lacZ mice, but their differentiation is impaired.
The expression of Hes1 in β-galactosidaseþ cells, as well as the
loss of Ascl1 expression in the lung might indicate that neu-
roendocrine cells in the Insm1 mutant mice have assumed a dif-
ferent fate, for instance the fate of CC10þ Clara cells or SSEAþ
epithelial progenitor cells (Morimoto et al., 2012). However, co-
expression of β-galactosidase with CC10 or SSEA was not observed
(Fig. 4A and B). Thus, despite the fact that neuroendocrine cells
ectopically express Hes1 and lose Ascl1 expression in Insm1 mu-
tants, they do not trans-differentiate but retain a memory of
having been speciﬁed as neuroendocrine cells.
Next we asked whether Insm1 is expressed in the lung of Ascl1
mutant mice. We detected no Insm1 protein in Ascl1/ mice,
indicating that Insm1 requires Ascl1 for the initiation of its ex-
pression (Fig. 4C).
3.3. Insm1 binds to sequences in the Hes1 gene and represses Hes1
Insm1 can bind to DNA directly and recruit other histone
Fig. 3. Ectopic expression of Hes1 in pulmonary neuroendocrine cells of Insm1 mutant mice. (A-C) Expression of β-gal (red) and Hes1 (green) in the lung epithelium of
control and Insm1mutant mice analyzed by immunohistology at the indicated developmental stages. High magniﬁcations of the indicated areas are shown twice. The insert
at the top shows β-gal and Hes1 co-staining; the insert at the bottom only shows only Hes1. (D–F) In situ hybridization analysis of Ascl1 expression in the lung of control and
Insm1 mutant mice at the indicated stages. (G) In situ hybridization analysis of Dll1 expression in the lung of control and Insm1 mutant mice at E18.5. Scale bars: 30 μm (A–
C); 150 μm (D–G).
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Fig. 4. Pulmonary neuroendocrine cells do not transdifferentiate in Insm1mutant mice. (A) Immunohistological analysis of β-gal (red) and CC10 (green) in the lung of control
(Insm1þ /lacZ) and Insm1 mutant (Insm1lacZ/lacZ) mice at E18.5. DAPI (blue) was used as a counterstain. High magniﬁcations of the indicated areas are shown twice. The insert
at the top shows β-gal, CC10 and DAPI co-staining; the insert at the bottom shows only CC10 and DAPI co-staining. (B) Immunohistological analysis of β-gal (red) and SSEA1
(green) in the lung of control (Insm1þ /lacZ) and Insm1 mutant (Insm1lacZ/lacZ) mice at E18.5. DAPI (blue) was used as a counterstain. High magniﬁcations of the indicated areas
are shown twice. The inset at the top shows β-gal, SSEA1 and DAPI co-staining; the inset at the bottom shows only SSEA1 and DAPI co-staining. (C) Immunohistological
analysis of Insm1 (red) in lung epithelium of control and Ascl1mutant mice at E13.5. Toto3 (green) was used as a nuclear counterstain. Scale bars: 30 μm (A and B); 50 μm (C).
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by other transcription factors (Breslin et al., 2002; Welcker et al.,
2013; Jia et al., 2015). We previously noted that Insm1 binds to
Hes1 sequences in pancreatic β-cells (Jia et al., 2015). We therefore
investigated whether Insm1 binds to these sites in pulmonary
neuroendocrine cells (Fig. 5A and Supplementary material Ta-
ble 1). Chromatin was isolated from whole lung tissue obtainedfrom E15.5 embryos, and immunoprecipitated using anti-Insm1
antibodies. The precipitated chromatin was analyzed for the pre-
sence of enriched sequences by PCR. We observed a strong en-
richment of three sequences associated with the Hes1 locus. These
sequences located to the promoter (P2), exon four (Ex) and a 5′
upstream region (P1), and they were enriched 7- to 9-fold com-
pared to an experiment in which a non-speciﬁc IgG was used
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S. Jia et al. / Developmental Biology 408 (2015) 90–98 97(Fig. 5B). No enrichment was observed for other tested sites of the
Hes1 gene that, in chromatin from pancreatic β-cells, were found
to bind Insm1 (Fig. 5B). In addition, a randomly selected sequence
located 11 kb downstream of the Hes1 locus was also not enriched
(Fig. 5B).
To test the sequences that bound Insm1 for transcriptional
regulatory activity, we used a luciferase reporter system. The
fragments were inserted into a luciferase vector containing a
minimal promoter (pGL4.23), and tested in HEK293 cells. The
presence of the P2 fragment from the Hes1 promoter stimulated
transcriptional activity by a factor of 250. The 5′ upstream frag-
ment (P1) and exon fragment (Ex) also increased expression 20-
and 5-fold, respectively, and the presence of all three fragments
stimulated transcription 200-fold (Fig. 5C). Thus, sequences bound
by Insm1 can have regulatory transcriptional activity.
We next tested whether co-transfection of Insm1 affects the
transcriptional activity of the regulatory sequences identiﬁed in
the Hes1 gene. After co-transfection of Insm1, we observed a sig-
niﬁcantly decreased expression when the promoter fragment (P2)
was used to drive luciferase expression. Transcriptional activities
of plasmids containing the exon sequence (Ex) or P1 were similar
in the absence or presence of Insm1. When Insm1 was co-trans-
fected with a vector containing all three fragments (P1, P2 and Ex),
luciferase activity decreased (Fig. 5C). In summary, Insm1 binds to
several sequences in the Hes1 gene. Among these, the promoter
fragment strongly increases transcriptional activity in a hetero-
logous system, and Insm1 represses the transcription of reporter
sequences driven by this regulatory sequence.
Next we used a non-small cell lung cancer cell line, LCLC97
cells, that expresses Hes1 but no or little Insm1 (Fig. 5D, bottom).
We tested whether the presence of Insm1 changes the expression
of the endogenous Hes1 gene by transfecting Insm1 cDNA. The
presence of Insm1 downregulated expression of the Hes1 gene
signiﬁcantly, but did not affect expression of the β-actin (Actb)
gene (Fig. 5D). Together, the data indicate that Insm1 binds the
Hes1 promoter in neuroendocrine cells of the lung, and that Insm1
can repress Hes1 expression.4. Discussion
Insm1 is expressed in developing and mature endocrine cell
types, and is detected in neuroendocrine tumors (Lan and Breslin,
2009). Previous studies identiﬁed an essential role of Insm1 in
development of endocrine cells in the pancreas, intestine, pituitary
and adrenal gland (Gierl et al., 2006; Wildner et al., 2008; Welcker
et al., 2013; Osipovich et al., 2014). Here we show that Insm1 acts
as a key regulator for differentiation of pulmonary neuroendocrine
cells. Mutation of Insm1 did not affect the initial speciﬁcation of
these cells, but blocked their terminal differentiation. The differ-
entiation deﬁcit was associated with upregulated expression of
Hes1. Notch signaling plays important roles in the speciﬁcation of
non-neuroendocrine cell types in the lung and needs to be re-
pressed during development of pulmonary neuroendocrine cells
(Morimoto et al., 2012). Our data indicate that Insm1 participates
in the regulation of the Notch signaling network by repressing
Hes1, an important effector of Notch signaling, and hereby allows
normal neuroendocrine differentiation of lung epithelial cells.
Mechanisms responsible for cell fate speciﬁcation in the pul-
monary epithelium have received considerable attention, but fac-
tors regulating terminal differentiation have not been identiﬁed.
We show here that after establishment of the neuroendocrine cell
fate, Insm1 needs to be present for the execution of the differ-
entiation program. In particular, Insm1 is essential for the repres-
sion of Hes1 in developing neuroendocrine cells. Using ChIP ex-
periments on lung tissue, we show that Insm1 directly binds tosequences in the Hes1 locus. Among these, sequences close to the
Hes1 promoter had the highest transcriptional regulatory activity.
Insm1 downregulated the transcriptional activity of Hes1 pro-
moter sequences, but not of other tested fragments. The Hes1
promoter contains in addition to the Insm1 binding site four
consensus recognition sequences of Hes1 (N-box sequences), and
these sequences bind Hes1 in gel shift experiments and have
regulatory function (Takebayashi et al., 1994). The overlapping
binding regions might indicate a regulatory interaction between
Insm1 and Hes1 proteins. Such regulatory interactions between
Insm1 and another bHLH protein, Neurod1, were previously
characterized in pancreatic β-cells. In particular, Insm1 can directly
bind Neurod1 and frequently co-occupies chromatin together with
Neurod1 and the forkhead factor Foxa2. Combinatorial Insm1/
Neurod1/Foxa2 binding sites represent high afﬁnity sites and
identify regulatory sequences that maintain the mature gene ex-
pression program in β-cells (Jia et al., 2015). Regulatory interac-
tions between Insm1 and Neurod1 might not be important during
the early differentiation of pulmonary neuroendocrine cells, since
Neurod1 expression is low or absent in the prenatal lung (Ito et al.,
2000). It might become operative postnatally when Neurod1 is
expressed in pulmonary neuroendocrine cells (Neptune et al.,
2008).
Insm1 contains a SNAG motive at its N-terminus, and we
showed previously that histone-modifying factors (Kdm1a, Hdac1/
2 and Rcor1-3) and other proteins implicated in transcriptional
regulation (Hmg20a/b and Gse1) are recruited to Insm1 via the
SNAG domain (Welcker et al., 2013). Thus, Insm1 can recruit his-
tone-modifying proteins to chromatin, and thus might repress
Hes1 expression in pulmonary neuroendocrine cells by epigenetic
mechanisms.
Insm1 controls development of endocrine and neuronal cells,
and similarities of the transcriptional hierarchies that regulate
Insm1 are emerging. For instance, Insm1 expression depends on
Ascl1 in pulmonary neuroendocrine cells, sympathetic neurons
and serotonergic and noradrenergic neurons of the hindbrain
in vivo (Wildner et al., 2008; Jacob et al., 2009 and data presented
here). Ascl1 might control initiation of expression of Insm1 directly
or indirectly in pulmonary neuroendocrine cells, but it interesting
to note that Insm1 is a direct Ascl1 target gene in the developing
brain (Castro et al., 2006; Jacob et al., 2009). In pancreatic endo-
crine cells, the initiation of Insm1 expression depends on Ngn3
encoding a distinct bHLH factor (Mellitzer et al., 2006). Thus, dif-
ferent bHLH factors act upstream to initiate Insm1 expression in
various cell types.
We show here that Insm1 expression is not initiated in Ascl1
mutants. In Insm1 mutants, Ascl1 expression is correctly initiated
but expression is profoundly downregulated at late stages of fetal
development, and this does not affect the activity of the Insm1
promoter as assessed by the expression of lacZ/β-galactosidase.
Therefore, the roles of Ascl1 in initiation and maintenance of
Insm1 expression differ. Ascl1 is known to act as pioneer factor
during neuronal differentiation (Vierbuchen et al., 2010; Raposo
et al., 2015). Pioneer factors bind sequences in closed chromatin
and open it, making the DNA accessible to other transcription
factors that then take over the regulation of gene expression. Such
a mechanism might be operative during development of neu-
roendocrine cells of the lung and make expression of β-galacto-
sidase independent of Ascl1 at late stages of differentiation.
We show here that loss of Insm1 results in increased Hes1 ex-
pression in pulmonary neuroendocrine cells. Upregulated Hes1
expression was recently also detected in Insm1 mutant endocrine
pituitary cells (Welcker et al., 2013). In addition, Insm1 binding
sites identiﬁed here in the Hes1 locus were chosen for a ChIP-PCR
experiment because these were previously identiﬁed as Insm1
binding sites in pancreatic β-cells (Jia et al., 2015). We observed
S. Jia et al. / Developmental Biology 408 (2015) 90–9898that a subset, but not all sites showed enrichment in ChIP-PCR
experiment using chromatin of pulmonary neuroendocrine cells.
This indicates that common Insm1 target genes exist in distinct
endocrine cell types, but that few of the regulatory sequences are
shared in the different endocrine cell types.Acknowledgments
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